Article Details

Royal Bank of Canada Boosts Enanta Pharmaceuticals (NASDAQ:ENTA) Price Target to $53.00

Retrieved on: 2021-02-09 12:45:00

Tags for this article:

Click the tags to see associated articles and topics

Royal Bank of Canada Boosts Enanta Pharmaceuticals (NASDAQ:ENTA) Price Target to $53.00. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 469,115 shares of the biotechnology company's stock worth $21,474,000 after buying an additional 55,730 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up